Search
forResearch 10 of 1000+
- Androgen antagonists in androgen target tissues
- Structure of human type II 5 alpha-reductase gene
- The Modulatable Stem Cell Niche: Tissue Interactions during Hair and Feather Follicle Regeneration
- Androgens and Cardiovascular Disease
- Serum prostate spesific antigen levels in women with androgenetic alopecia
- Hypothalamic lipid metabolism and the control of food intake
- Unravelling the link between insulin resistance and androgen excess
- A hypothetical pathogenesis model for androgenic alopecia: clarifying the dihydrotestosterone paradox and rate-limiting recovery factors
- In-vivo uptake and metabolism of testosterone by the skin and other tissues of the rat
- Human type 3 5α-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride
Community 9 of 345
- Is there a topical androgen receptor blocker so we don't have to fuck with the enzyme and destroy our allopregnanolone, but go and hit the end target straight?
- Target Area Hair Count (TAHC) increase comparasion of all future treatments in clinical trial phases
- Could a reversed SARM designed for the scalp serve as a replacement for oral Dut and Fin?
- Gt20026 - the actual cure to hairloss?
- Is there any new drug that looks promising ?
- End of Hair loss ( AGA ) ? Since they produce it in china probably we don’t need to wait other 10 yrs😁
- Why some people experience problems on Finasteride/Dutasteride (my theory)
- GT20029 and PP405 the new fin and min that we been waiting for ?
- Are there ever going to be any oral DHT blocking treatments in the future?